Actavia Life Sciences (Actavia Life Sciences) Scaled Net Operating Assets : -72.23 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Actavia Life Sciences Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Actavia Life Sciences's operating assets for the quarter that ended in Mar. 2024 was $0.05 Mil. Actavia Life Sciences's operating liabilities for the quarter that ended in Mar. 2024 was $1.93 Mil. Actavia Life Sciences's Total Assets for the quarter that ended in Dec. 2023 was $0.03 Mil. Therefore, Actavia Life Sciences's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was -72.23.

Actavia Life Sciences Scaled Net Operating Assets Historical Data

The historical data trend for Actavia Life Sciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actavia Life Sciences Scaled Net Operating Assets Chart

Actavia Life Sciences Annual Data

Trend

Jun14

Jun15

Jun16

Mar17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.53

-0.44

-63.06

-33.51

-21.41

Actavia Life Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															-27.10	-33.87	-49.19	-19.76	-72.23

Competitive Comparison of Actavia Life Sciences's Scaled Net Operating Assets

For the Biotechnology subindustry, Actavia Life Sciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Actavia Life Sciences's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actavia Life Sciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Actavia Life Sciences's Scaled Net Operating Assets falls into.

Actavia Life Sciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Actavia Life Sciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Sep. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Sep. 2023 )
=	(Operating Assets (A: Sep. 2023 )	-	Operating Liabilities (A: Sep. 2023 ))	/	Total Assets (A: Sep. 2022 )
=	(0.021	-	1.841)	/	0.085
=	-21.41

where

	Operating Assets		(A: Sep. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.096	-	0.075
=	0.021

	Operating Liabilities		(A: Sep. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2.052	-	0	-	0.211
=	1.841

Actavia Life Sciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(0.048	-	1.926)	/	0.026
=	-72.23

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.049	-	0.001
=	0.048

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2.23	-	0	-	0.304
=	1.926

Actavia Life Sciences Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Actavia Life Sciences's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Actavia Life Sciences (Actavia Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actavia Life Sciences Inc (OTCPK:RASP) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Lexington Avenue, Suite 2525, New York, NY, USA, 10170

Website

https://www.rasna.com

Rasna Therapeutics Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.

Actavia Life Sciences (Actavia Life Sciences) Headlines

No Headlines